Paradoxical increase in uric acid level with allopurinol use in pyrazinamide-induced hyperuricaemia

Creative Commons License

Gerdan V., Akkoc N., UÇAN E. S., Kir S. B.

SINGAPORE MEDICAL JOURNAL, cilt.54, sa.6, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 54 Sayı: 6
  • Basım Tarihi: 2013
  • Doi Numarası: 10.11622/smedj.2013097
  • Dergi Adı: SINGAPORE MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: allopurinol, antitubercular agents, tuberculosis, uric acid, TUBERCULOSIS, ETHAMBUTOL, MANAGEMENT
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

We report the case of a 36-year-old man with psoriatic arthritis and miliary tuberculosis, whose serum uric acid (SUA) level increased after the initiation of antituberculosis treatment, which included pyrazinamide. Most strikingly and paradoxically, the patient's SUA level increased after treatment with allopurinol. On cessation of allopurinol, his SUA level decreased substantially, and complete normalisation was observed following the discontinuation of pyrazinamide treatment.